AG0032C4

3465-72-3 | (E)-3-(4-Imidazolyl)acrylic acid

AG0032C4

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	3465-72-3
Catalog Number	AG0032C4(AGN-PC-0O95VH)
Chemical Name	(E)-3-(4-Imidazolyl)acrylic acid
EC Number	203-258-4
IUPAC Name	(E)-3-(1H-imidazol-5-yl)prop-2-enoic acid
InChI	InChI=1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/b2-1+
InChI Key	LOIYMIARKYCTBW-OWOJBTEDSA-N
MDL Number	MFCD00149316
Molecular Formula	C6H6N2O2
Molecular Weight	138.1240
SMILES	N1C=NC(=C1)/C=C/C(=O)O
UNII	G8D26XJJ3B
Synonyms	Acid, Glyoxalinylacrylic, Acid, Urocanic, Glyoxalinylacrylic Acid, Urocanic Acid, urocanic acid, 4-imidazoleacrylic acid, trans-Urocanic acid, 104-98-3, Urocaninic acid, imidazoleacrylic acid, 3465-72-3, 5-Imidazoleacrylic acid, urocanate, Imidazole-4-acrylic acid, (2E)-3-(1H-IMIDAZOL-4-YL)ACRYLIC ACID, 3-Imidazol-4-ylacrylic acid, 3-(1H-Imidazol-4-yl)-2-propenoic acid, (2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid, UNII-G8D26XJJ3B, (E)-3-(1H-Imidazol-4-yl)-2-propenoic acid, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, NSC 66357, UROCANIC ACID, CIS, G8D26XJJ3B, (e)-3-(1h-imidazol-4-yl)acrylic acid, 3-(4-Imidazolyl)acrylic acid, MLS000069482, CHEBI:30817, LOIYMIARKYCTBW-OWOJBTEDSA-N, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (2E)-, (E)-3-(1H-imidazol-5-yl)acrylic acid, 3-(1H-imidazol-4-yl)prop-2-enoic acid, SMR000059098, Imidazole-4-propene-2-enoic acid [Urocanic acid], 4-IMIDAZOLE ACRYLIC ACID DIHYDRATE, CCRIS 3414, EINECS 203-258-4, (E)-Urocanic acid, BRN 0081405, (2E)-3-imidazol-4-ylprop-2-enoic acid, (E)-3-(imidazol-4-yl)propenoate, 5-Imidazoleacrylate, zlchem 24, MFCD00005203, Imidazole-4-acrylate, imidazolylpropenoicacid, PubChem9875, (E)-3-(1H-Imidazol-5-yl)-2-propenoic acid, (Z)-3-(3H-imidazol-4-yl)prop-2-enoic Acid, AC1LEIQR, Opera_ID_26, 3-(4-Imidazolyl)acrylate, bmse000279, AC1Q5T9G, AC1Q71IX, DSSTox_CID_21148, DSSTox_RID_79635, DSSTox_GSID_41148, Lopac0_001255, SCHEMBL15417, trans-4-imidazoleacrylic acid, MLS001148240, 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (E)-, 4-Imidazoleacrylic acid, 99%, AC1Q71Y1, Jsp000483, 3-(1H-Imidazol-4-yl)acrylate, CHEMBL1236602, DTXSID5041148, CHEBI:27248, ZLB0011, E-3-(4-imidazolyl)propenoic acid, HMS2234N08, HMS3263L12, ACT02032, ALBB-025618, NSC66357, (E)-3-(4-Imidazolyl)acrylic acid, Tox21_202978, Tox21_501255, BBL027507, MFCD01593677, NSC-66357, NSC407934, SBB006702, STK735136, ZINC34633903, (E)-3-(imidazol-4-yl)acrylic acid, 3-(3H-Imidazol-4-yl)-acrylic acid, 3-(1H-Imidazol-4-yl)-2-propenoate, AKOS001745677, AKOS005265082, AKOS022488522, (e)-3-(Imidazol-4-yl)propenoic acid, CCG-205329, DB01971, HS-0075, LP01255, NSC-407934, RP09780, RTR-032578, NCGC00094495-01, NCGC00094495-02, NCGC00094495-03, NCGC00260524-01, NCGC00261940-01, CAS-104-98-3, CJ-18538, LS-78025, SC-00208, ST085933, 3-(1H-Imidazol-5-yl)-2-Propenoic acid, 3-Azonia-1H-imidazole-5-acrylic acidanion, HY-113008, TR-032578, CS-0059340, EU-0101255, I0002, R1116, (E)-3-(1H-imidazol-4-yl)prop-2-enoic acid, (E)-3-(1H-imidazol-5-yl)prop-2-enoic acid, 3-(1H-Imidazol-4-yl)-(E)-2-Propenoic acid, C00785, U 7500, (2E)-3-(1H-imidazol-5-yl)prop-2-enoic acid, (2E)-3-(3H-imidazol-4-yl)prop-2-enoic acid, SR-01000076189, I04-0134, SR-01000076189-1, W-108797, 23A7DA77-EC02-46B9-AA22-514C2B2A62E9, 3-(1h-imidazol-4-yl)-2-propenoicaci ;3-(1h-imidazol-4-yl)-2-propenoicacid, cis-Urocanic acid, trans-urocanate, ProtoCure, Acid, Urocanic, -3- propenoicacid, Glyoxalinylacrylic Acid, Acid, Glyoxalinylacrylic, 3-imidazol-4-ylacrylsyre, D04CQV, 3-(1H-imidazol-4-yl)acrylic acid, (Z)-Imidazole-4-acrylic acid, C6H6N2O2, 3- imidazol- 4- ylacrylic acid, C6-H6-N2-O2, AR-1E5184, CID736715, (2E)-3-(1H-Imidazole-4-yl)propenoic acid, 2-Propenoic acid, 3-(1H-imidazol-5-yl)-, A13624, 4-25-00-00786 (Beilstein Handbook Reference), D014560, ProtoCure (emulsion, atopic dermatitis), Biocis Pharma, ProtoCure (emulsion, atopic dermatitis/psoriasis), Laurantis, Anti-inflammatory (topical emulsion, dermatological disease), BioCis, Cis-UCA (topical emulsion, atopic dermatitis/psoriasis), Laurantis, ProtoCure (emulsion, atopic dermatitis/psoriasis), Biocis Pharma, 7699-35-6, Cis-UCA (topical emulsion, atopic dermatitis/psoriasis), BioCis Pharma, URO, Cis-urocanic acid (topical emulsion, atopic dermatitis/psoriasis), BioCis Pharma, 10557-55-8,

Complexity	156
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Exact Mass	138.043g/mol
Formal Charge	0
Heavy Atom Count	10
Hydrogen Bond Acceptor Count	3
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	138.126g/mol
Monoisotopic Mass	138.043g/mol
Rotatable Bond Count	2
Topological Polar Surface Area	66A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number